Manas Behera
Overview
Explore the profile of Manas Behera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sharma H, Prasad N, Kaul A, Bhaduria D, Patel M, Behera M, et al.
Indian J Nephrol
. 2024 Dec;
34(6):589-596.
PMID: 39649324
Background: Renal involvement in sarcoidosis is rare. We evaluated the pattern of renal involvement in sarcoidosis, its clinical course, renal histology, and response to treatment. Materials And Methods: We retrospectively...
2.
Prasad N, Meyyappan J, Dhanorkar M, Kushwaha R, Mandal K, Veeranki V, et al.
Clin Kidney J
. 2024 Aug;
17(8):sfae218.
PMID: 39135934
Background: Idiopathic nephrotic syndrome (NS) in children poses treatment challenges, with a subset developing steroid-resistant nephrotic syndrome (SRNS). Genetic factors play a role, yet data on paediatric SRNS genetics in...
3.
Marak R, Abdullah , Behera M, Kaul A, Bhadauria D, Prasad N, et al.
Transpl Immunol
. 2024 Mar;
84:102041.
PMID: 38537681
Introduction: Kidney transplant recipients are at increased risk of opportunistic infections, including Nocardia. The incidence of nocardiosis in kidney transplant recipients is 0.4-1.3%. The data regarding its epidemiology and outcomes...
4.
Abdullah , Momin I, Kaul A, Bhadauria D, Prasad N, Behera M, et al.
Transpl Immunol
. 2024 Feb;
83:102012.
PMID: 38403198
Introduction: The incidence of post-transplant diabetes mellitus (PTDM) ranges from 2.5% to 20% in kidney transplant recipients. Diabetic retinopathy (DR), diabetic kidney disease (DKD), and distal symmetric polyneuropathy (DSPN) are...
5.
Prasad N, Khurana M, Behera M, Yaccha M, Bhadauria D, Agarwal V, et al.
Indian J Nephrol
. 2023 May;
33(1):12-21.
PMID: 37197052
Introduction: Immunoglobulin A nephropathy (IgAN) is the most common glomerulonephritis worldwide, but there is a marked geographic difference in its prevalence and prognosis. IgAN is known to have an aggressive...
6.
Panda P, Dash P, Behera M, Mishra T
Res Sq
. 2023 Mar;
PMID: 36993240
Epidemiological transition in India shows a shift in disease burden from youth to the elderly. As Life Expectancy increases, a greater burden is placed on the state, society, and families...
7.
Prasad N, Veeranki V, Bhadauria D, Kushwaha R, Meyyappan J, Kaul A, et al.
J Clin Med
. 2023 Feb;
12(4).
PMID: 36836240
Background And Objectives: Owing to changing epidemiology and therapeutic practices, a change in the spectrum of renal involvement in Type-2 diabetes mellitus (T2DM) has also been noted. The treatment of...
8.
Prasad N, Khurana M, Kushwaha R, Patel M, Bhaduaria D, Kaul A, et al.
Int Urol Nephrol
. 2023 Feb;
55(7):1847-1855.
PMID: 36781681
Background: Diffuse crescentic IgAN (CIgAN) is an uncommon phenotype of IgAN, which presents as rapidly progressive renal failure, similar to patients with pauci-immune crescentic glomerulonephritis(PCGN). There are limited data on...
9.
Chandrashekhar P, Kaul A, Bhaduaria D, Prasad N, Behera M, Kushwaha R, et al.
Transpl Infect Dis
. 2022 Oct;
24(6):e13963.
PMID: 36306185
Background: Rituximab is an anti-CD 20 agent used widely in renal transplant recipients. Its use is associated with various infections; however, its association with tuberculosis (TB) is not well established...
10.
Khurana M, Prasad N, Behera M, Yachha M, Kushwaha R, Agarwal V, et al.
Indian J Nephrol
. 2022 Aug;
32(4):312-319.
PMID: 35967532
Background: The data on long-term outcomes of posttransplant immunoglobulin A nephropathy (IgAN) are confounding and vary with geography and ethnicity worldwide. We aimed to study the long-term graft outcomes of...